Paoli Hospital, part of Main Line Health, is a 231-bed, not-for-profit, acute care hospital in Paoli, Pennsylvania. In 2014, the hospital was re-accredited as a Level II Trauma Center, the only one in Chester County.

There are 231 beds in Paoli Memorial Hospital.

During the past decade, Paoli Memorial Hospital conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 78 clinical trials were completed, i.e. on average, 104% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 43 clinical trials were completed. i.e. 143.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Paoli Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 83 trials, followed by "SWOG Cancer Research Network" with 19 trials sponsored, "Radiation Therapy Oncology Group" with 15 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "Fox Chase Cancer Center" with 12 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Paoli Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 91 trials as a collaborator, "NRG Oncology" with 30 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "Radiation Therapy Oncology Group" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Paoli Memorial Hospital" are "Breast Cancer" (8 trials), "Invasive Breast Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials) and "Recurrent Breast Carcinoma" (7 trials). Many other conditions were trialed in "Paoli Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Paoli Memorial Hospital" are "Drug" (141 trials), "Other" (105 trials), "Biological" (65 trials), "Procedure" (42 trials) and "Radiation" (42 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (55 trials), "Quality-of-Life Assessment" (44 trials), "Questionnaire Administration" (30 trials), "Paclitaxel" (28 trials) and "Carboplatin" (20 trials). Other intervention names were less common.

The vast majority of trials in "Paoli Memorial Hospital" are 127 trials for "All" genders, 46 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Paoli Memorial Hospital". undefined are not yet recruiting, 29 are recruiting, 67 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 65 completed trials in Paoli Memorial Hospital, 2 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Paoli Memorial Hospital, 3 "Phase 1" clinical trials were conducted, 80 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".